Search

Clark, J, JM Silvaggi, T Kiselak, K Zheng, E Clore, Y Dai, CE Bass, and DK Simon. 2012. “Pgc-1α Overexpression Downregulates Pitx3 and Increases Susceptibility to MPTP Toxicity Associated With Decreased Bdnf”. PLoS ONE.

St-Pierre, Julie, Stavit Drori, Marc Uldry, Jessica M Silvaggi, James Rhee, Sibylle Jäger, Christoph Handschin, et al. 2006. “Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional Coactivators”. Cell.

Clark, Joanne, Elizabeth L Clore, Kangni Zheng, Anthony Adame, Eliezer Masliah, and David K Simon. 2010. “Oral N-Acetyl-Cysteine Attenuates Loss of Dopaminergic Terminals in α-Synuclein Overexpressing Mice”. PLOS ONE.

Dai, Ying, Kangni Zheng, Joanne Clark, Russell H Swerdlow, Stefan M Pulst, James P Sutton, Leslie A Shinobu, and David K Simon. 2014. “Somatic Mitochondrial DNA Mutations Do Not Increase Neuronal Vulnerability to MPTP in Young POLG Mutator Mice.”

Baumgartner, Alexander J, Daniel Z. Press, and David K. Simon MD. 2021. “The Relationship Between Olfactory Dysfunction and Constipation in Early Parkinson’s Disease”. Movement Disorders.

Simon, David K. 2021. “A New Approach to the Development of Disease-Modifying Therapies for PD”. Movement Disorders.

Simon, David K., Caroline M. Tanner, and Patrik Brundin. 2020. “Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology”. Clinical Geriatric Medicine.

Frank, Samuel, Sarah Berk, Laura Hernandez, Penelope Hogarth, Holly A Shill, Bernadette Siddiqi, and David K Simon. 2019. “Transportation Innovation to Aid Parkinson Disease Trial Recruitment”. Contemporary Clinical Trials Communications.

Demetrius, LA, and DK Simon. 2013. “The Inverse Association of Cancer and Alzheimer’s: A Bioenergetic Mechanism”. Journal of the Royal Society Interface.

Lin, MT, I Cantuti-Castelvetri, K Zheng, KE Jackson, YB Tan, T Arzberger, AJ Lees, RA Betensky, MF Beal, and DK Simon. 2012. “Somatic Mitochondrial DNA Mutations in Early Parkinson’s and Incidental Lewy Body Disease”. Annals of Neurology.